Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Medical Device Analytical Testing Outsourcing Market, By Service Type
7.1. Medical Device Analytical Testing Outsourcing Market, By Service Type, 2020-2027
7.1.1. Extractable and leachable
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Material characterization
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Physical testing
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Bioburden testing
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Sterility testing
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Other tests
7.1.6.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Medical Device Analytical Testing Outsourcing Market, By Therapeutic Areas
8.1. Medical Device Analytical Testing Outsourcing Market, By Therapeutic Areas, 2020-2027
8.1.1. Cardiology
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Diagnostic Imaging
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Orthopedic
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. IVD
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Ophthalmic
8.1.5.1. Market Revenue and Forecast (2016-2027)
8.1.6. General & Plastic Surgery
8.1.6.1. Market Revenue and Forecast (2016-2027)
8.1.7. Drug Delivery
8.1.7.1. Market Revenue and Forecast (2016-2027)
8.1.8. Endoscopy
8.1.8.1. Market Revenue and Forecast (2016-2027)
8.1.9. Dental
8.1.9.1. Market Revenue and Forecast (2016-2027)
8.1.10. Diabetes Care
8.1.10.1. Market Revenue and Forecast (2016-2027)
8.1.11. Others
8.1.11.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Medical Device Analytical Testing Outsourcing Market, By Type
9.1. Medical Device Analytical Testing Outsourcing Market, By Type, 2020-2027
9.1.1. Reprocessed Devices
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Others
9.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Medical Device Analytical Testing Outsourcing Market, By End-Use Type
10.1. Medical Device Analytical Testing Outsourcing Market, By End-Use Type, 2020-2027
10.1.1. Hospital
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Others
10.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 11. Global Medical Device Analytical Testing Outsourcing Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.1.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.1.3. Market Revenue and Forecast, By Type (2016-2027)
11.1.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.1.5.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.1.5.3. Market Revenue and Forecast, By Type (2016-2027)
11.1.5.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.1.6.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.1.6.3. Market Revenue and Forecast, By Type (2016-2027)
11.1.6.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.2.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.2.3. Market Revenue and Forecast, By Type (2016-2027)
11.2.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.2.5.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.2.5.3. Market Revenue and Forecast, By Type (2016-2027)
11.2.5.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.2.6.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.2.6.3. Market Revenue and Forecast, By Type (2016-2027)
11.2.6.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.2.7.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.2.7.3. Market Revenue and Forecast, By Type (2016-2027)
11.2.7.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.2.8.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.2.8.3. Market Revenue and Forecast, By Type (2016-2027)
11.2.8.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.3.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.3.3. Market Revenue and Forecast, By Type (2016-2027)
11.3.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.3.5.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.3.5.3. Market Revenue and Forecast, By Type (2016-2027)
11.3.5.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.3.6.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.3.6.3. Market Revenue and Forecast, By Type (2016-2027)
11.3.6.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.3.7.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.3.7.3. Market Revenue and Forecast, By Type (2016-2027)
11.3.7.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.3.8.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.3.8.3. Market Revenue and Forecast, By Type (2016-2027)
11.3.8.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.4.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.4.3. Market Revenue and Forecast, By Type (2016-2027)
11.4.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.4.5.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.4.5.3. Market Revenue and Forecast, By Type (2016-2027)
11.4.5.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.4.6.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.4.6.3. Market Revenue and Forecast, By Type (2016-2027)
11.4.6.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.4.7.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.4.7.3. Market Revenue and Forecast, By Type (2016-2027)
11.4.7.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.4.8.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.4.8.3. Market Revenue and Forecast, By Type (2016-2027)
11.4.8.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.5.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.5.3. Market Revenue and Forecast, By Type (2016-2027)
11.5.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.5.5.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.5.5.3. Market Revenue and Forecast, By Type (2016-2027)
11.5.5.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Service Type (2016-2027)
11.5.6.2. Market Revenue and Forecast, By Therapeutic Areas (2016-2027)
11.5.6.3. Market Revenue and Forecast, By Type (2016-2027)
11.5.6.4. Market Revenue and Forecast, By End-Use Type (2016-2027)
Chapter 12. Company Profiles
12.1. SGS SA
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Toxikon, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Eurofins Scientific
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Pace Analytical Services, LLC
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Intertek Group plc
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. WuXi AppTec.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. NORTH AMERICAN SCIENCE ASSOCIATES INC.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Envigo
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Charles River Laboratories International Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Medical Device Testing Services
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms